See All Slides - tctmd.com

Slides

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

Presenter: Kenneth Borow

January 22, 2013

Presentation

Same-Day Discharge Compared with Overnight Hospitalization After Uncomplicated PCI

Presenter: E. Abdelaal

January 22, 2013

Presentation Cell Therapy 2013

EXCELLENT Trial Design

Presenter: J?r?me Roncalli

January 22, 2013

Presentation

Comparison of BMS with Minimally Invasive Bypass Surgery for Stenosis of the LAD Coronary Artery

Presenter: S. Blazek

January 22, 2013

Presentation Cell Therapy 2013

Update CD133 BMSC in CABG Surgery

Presenter: Gustav Steinhoff

January 22, 2013

Presentation Cell Therapy 2013

A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to PCI in Subjects Presenting with STEMI

Presenter: Frank J. Giordano

January 22, 2013

Presentation Cell Therapy 2013

Adipose-Derived Regenerative Cells in Chronic Ischemic Heart Disease

Presenter: Emerson C. Perin

January 22, 2013

Presentation Cell Therapy 2013

IMPACT Clinical Trial Program: Findings and Strategic Update

Presenter: Jay H. Traverse

January 22, 2013

Presentation Cell Therapy 2013

Biologic Therapy For Claudication FIM Strategy

Presenter: Todd J. Brinton

January 22, 2013

Presentation Cell Therapy 2013

Adipose derived cells or chronic myocardial ischemia

Presenter: Francisco Fdez-Avil?s

January 22, 2013

Advertisement

Slides

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

Same-Day Discharge Compared with Overnight Hospitalization After Uncomplicated PCI

EXCELLENT Trial Design

Comparison of BMS with Minimally Invasive Bypass Surgery for Stenosis of the LAD Coronary Artery

Update CD133 BMSC in CABG Surgery

A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to PCI in Subjects Presenting with STEMI

Adipose-Derived Regenerative Cells in Chronic Ischemic Heart Disease

IMPACT Clinical Trial Program: Findings and Strategic Update

Biologic Therapy For Claudication FIM Strategy

Adipose derived cells or chronic myocardial ischemia

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content